Invention Grant
US08394768B2 Synergistic therapeutic use of Prothrombin Complex Concentrates with FVIII concentrates
有权
凝血酶原复合物浓缩物与FVIII浓缩物的协同治疗用途
- Patent Title: Synergistic therapeutic use of Prothrombin Complex Concentrates with FVIII concentrates
- Patent Title (中): 凝血酶原复合物浓缩物与FVIII浓缩物的协同治疗用途
-
Application No.: US12520773Application Date: 2007-12-18
-
Publication No.: US08394768B2Publication Date: 2013-03-12
- Inventor: Gerhard Dickneite
- Applicant: Gerhard Dickneite
- Applicant Address: DE Marburg
- Assignee: CSL Behring GmbH
- Current Assignee: CSL Behring GmbH
- Current Assignee Address: DE Marburg
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Priority: EP06026748 20061222
- International Application: PCT/EP2007/011099 WO 20071218
- International Announcement: WO2008/077529 WO 20080703
- Main IPC: A61K38/36
- IPC: A61K38/36 ; A61K38/00 ; A61P7/02 ; A61P7/00 ; C07K14/745
Abstract:
The field of the invention is the treatment of acquired bleeding, a clinical condition associated with severe traumatic, peri- or post-operative bleeding. A novel treatment is proposed in which synergistic procoagulatory properties of Prothrombin Complex Concentrates (PCC) together with medicaments comprising FVIII and/or vWF are exploited.
Public/Granted literature
- US20100093607A1 SYNERGISTIC THERAPEUTIC USE OF PROTHROMBIN COMPLEX CONCENTRATES WITH FVIII CONCENTRATES Public/Granted day:2010-04-15
Information query
IPC分类:
